IN THE NEWS
Clinical Trials Arena
October 23, 2025Crystalys Therapeutics begins Phase III trials for gout treatment
Pharmaceutical Technology
October 23, 2025Biotechs brush off sector headwinds in venture financing rebound
FirstWord Pharma
September 30, 2025Crystalys makes its debut with $205M to advance next-gen gout drug
Fierce Biotech
September 30, 2025James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise
Reuters
September 30, 2025Crystalys Therapeutics launches with $205 million funding round for trials of gout drug
Endpoints News
September 30, 2025